The speakers highlight emerging trends in GLP-1 therapy, including personalized dosing, weight maintenance, combination ...
AZoM on MSN
How much silver is in silver jewelry?
Sterling silver is a common alloy in jewelry, with 92.5 % pure silver and 7.5 % of an additional metal, such as copper or ...
Judith Hey-Hadavi and Nicole Snow discuss GLP-1 receptor agonists, emphasizing personalized dosing, side effect management, ...
Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction in countable motor seizure frequency (CMSF) compared with placebo1Holistic ...
Xenon Pharmaceuticals Inc. , a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need ...
A roundup of the most newsworthy healthcare press releases from PR Newswire, including new company mergers, Alzheimer's ...
The 2026 update to the ADA’s Standards of Care in Diabetes introduces new guidance on a wide range of topics, including the ...
New recommendations on glycemic management for people with cancer, continuous glucose monitoring and the use of ...
AZoM on MSN
What is the acid content of wine?
There are a variety of acids present in wine, the most common of which are tartaric and malic acids. Their quantities vary ...
Small bursts of mindfulness practices lasting a minute or less can have unexpected benefits for those with busy lives - ...
UCB, a global biopharmaceutical company, today presented positive efficacy and safety results from the GEMZ phase 3 study investigating adjunctive fenfluramine (FFA) in children and adults with CDKL5 ...
On a video call in early September, Sarah Tabrizi first saw the data that she and other researchers studying Huntington’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback